Moderna (MRNA)

Operating Cash Flow Growth

60.99%

TTM · Period ending:

MRNA logo

MRNA Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported60.99%
MRNA TTM Cash from Operations YoY % (0.19% → 60.99%)
High-resolution chart · PNG

MRNA operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Moderna Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
60.9937%
52.654%
38.3489%
38.3224%
16.7849%
-5.8987%
3.6562%
-54.3311%
-1,334.0708%
-390.2316%
-162.5979%
-131.3471%
-102.3412%
-92.5962%
-63.4288%
-42.7265%
5.0262%
162.766%
571.9386%
1,635.5125%
2,861.0081%
1,311.7223%
541.6367%
246.8267%
22.1095%
-15.9119%
-38.7176%
-32.5123%
-40.0408%
-3.8601%
0.1867%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.